Neuren Pharmaceuticals Ltd (NEU.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Operating Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -12 | N/A | N/A | -10 | 1 |
| Investing Cash Flow | $-12 | $N/A | $N/A | $-10 | $1 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,860 | 11,730 | 11,500 | 929 | 7,561 |
| Common Stock Repurchased | N/A | -16 | -44 | -12 | -12 |
| Other Financing Activity | 0 | 0 | -6,133 | 0 | 0 |
| Financing Cash Flow | $1,860 | $11,714 | $5,323 | $917 | $7,549 |
| Exchange Rate Effect | 141 | 748 | -78 | -120 | 999 |
| Beginning Cash Position | 23,576 | 4,706 | 5,051 | 16,642 | 20,824 |
| End Cash Position | 13,846 | 23,576 | 4,706 | 5,051 | 16,642 |
| Net Cash Flow | $-9,871 | $18,122 | $-267 | $-11,471 | $-5,181 |
| Free Cash Flow | |||||
| Capital Expenditure | -12 | N/A | N/A | -10 | -3 |
| Free Cash Flow | -12 | 0 | 0 | -10 | -3 |